Our team has held operational roles and been accountable for all aspects of the bio-pharmaceutical business. We bring the breadth and depth of our expertise to offer seamless and comprehensive advisory services to life science companies at all stages.
We supported the CEO in defining a corporate strategy for a new therapeutic division
Our job is to define and execute a strategy to find the right global partners for PARP+
Like BioCision, we helped MedCision with a strategic plan, valuation and pitch deck getting them off the ground
We are excited about this technology and are proud to be Gigagen’s BD advisors
Our analysis helped evolve the specs for a diagnostic test optimizing its commercial value
We plan to find the right partner to help this novel gene therapy for pain get to patients
Our 5-year corporate strategic plan supported year-over-year growth and an exit in year 5!
We are Biom’Up’s corporate strategic advisors and analytic arm supporting portfolio investments
We ran a process to create and evaluate strategic options that led to a $35M financing
Excited to have been a part of two transactions that sent their market cap over $1B
Case StudyOur business guidance enabled fundraising and a merger that got IMNP NASDAQ listed
We helped this lung cancer test get to market, benefit patients, and save lives
Our analysis shed light on a clear development path and value proposition to potential partners
Our commercial assessment and positioning inspired investing to the next value infection point
We provided an outsider’s view to pressure-test internal thinking on pipeline development
We helped this incubator create a data-driven development plan for a portfolio company
